IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation

NCT01931865 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped lost the recruiting source- no recruitment for the past 18months, PI moving

Conditions

Pain

Interventions

DRUG: IncobotulinumtoxinA

Sponsor

Yale University

Collaborators

[object Object]